Camlin Fine Sciences Limited — Board Meeting, 10-11-2025: Outcome of Board Meeting
10-11-2025 | 03:59 pm
10-11-2025 | 03:59 pm
Camlin Fine Sciences' board approved the financial results for the quarter and half-year, reporting a consolidated loss of ₹25.63 Cr on revenues of ₹883.38 Cr. Key decisions include re-appointing an Independent Director, subject to shareholder approval, and granting 16.23 lakh employee stock options.
No comments yet. Be the first to comment!
